SPRO (Spero Therapeutics, Inc. Common Stock) Stock Analysis - Politician Trades
Spero Therapeutics, Inc. Common Stock (SPRO) is a publicly traded Healthcare sector company. As of May 21, 2026, SPRO trades at $2.63 with a market cap of $149.39M and a P/E ratio of 0.00. SPRO moved +1.16% today. Year to date, SPRO is +8.23%; over the trailing twelve months it is +286.65%. Its 52-week range spans $0.51 to $3.22. Rallies surfaces SPRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded SPRO stock?
Rallies tracks politician and congressional stock disclosures for SPRO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Rajavelu Esther sold 25.24K (~$63.35K) on May 4, 2026.
Rajavelu Esther sold 37.10K (~$87.56K) on Feb 6, 2026.
Rajavelu Esther sold 50.82K (~$119.93K) on Feb 6, 2026.
SPRO Analyst Consensus
SPRO analyst coverage data. Average price target: $0.00.
Common questions about SPRO
Which politicians traded SPRO stock?
Rallies tracks politician and congressional stock disclosures for SPRO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in SPRO?
Yes. Rallies tracks politician and congressional stock disclosures for SPRO, including reported purchases, sales, dates, owners, and trade amounts when available.
Is SPRO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SPRO. It does not provide personalized investment advice.